Chest
-
As seen in this CME online activity (available at http://courses.elseviercme.com/730), COPD is the third leading cause of death in the United States among people 65 years of age and older and the fourth leading cause of death among people 45 to 65 years of age. A recent survey reported that about 12 to 15 million people in the United States have physician-diagnosed COPD. However, COPD is significantly underdiagnosed, and data suggest as many as 12 million people in the United States have undiagnosed COPD. ⋯ This CME-certified webcast provides insights into new approaches to identifying patients with undiagnosed COPD, the importance of early initiation of pharmacologic treatment in a guideline-congruent manner, and the importance of repeated patient training in correct inhaler techniques to improve adherence and patient outcomes. Additionally, the online program is part of a larger learning platform (available at https://copd.elsevierresource.com/) that provides free access to the latest clinical information related to the diagnosis and management of COPD. The COPD Learning Center is a freely accessible platform that aims to increase clinical knowledge by providing CME activities, research articles, and resources for health-care providers who treat patients with COPD.
-
Idiopathic pulmonary fibrosis is the most common idiopathic interstitial pneumonia. Prognosis is poor with a median survival <3 years. Pirfenidone is one of two US Food and Drug Administration-approved medications that slow disease progression. We describe the development of lymphadenopathy or a sarcoid-like reaction following initiation of pirfenidone, a complication not previously reported.